Insights
July 23, 2026

The Clinical Trial Enrollment Dilemma: Why Upstream Strategy Determines Downstream Success: A Perspective on Reimagining Clinical Trial Enrollment and Retention. By Vani Nilakantan, PhD Founder, Sikara Consultancy LLC

Clinical trials remain the backbone of medical innovation, yet the industry continues to face a persistent and costly paradox: despite unprecedented scientific advancement, most trials struggle to enroll and retain participants. The data is sobering. Nearly 80% of clinical trials experience delays or premature termination due to recruitment challenges, and 37% of research sites fail to enroll an adequate number of volunteers with 11%enrolling none (Clinical Trials.gov).

At Sikara, we believe the industry must shift from reactive enrollment tactics to proactive, system‑level readiness. This requires rethinking feasibility, redesigning workflows, and elevating research as a strategic asset within health systems.

Why Patients Disengage

Modern protocols are more ambitious than the infrastructure meant to support them. Limited resources, financial constraints and operational burden make it challenging to meet enrollment targets for many sites.

Most patients never enter the pipeline because they never hear about the trial in the first place as there is little to no awareness of clinical trials or research in communities.

Underrepresented communities face structural barriers that are rarely addressed upstream.

CRC burnout is at an all-time high,driven by unrealistic workloads and administrative burden. When staff areoverwhelmed, patient engagement inevitably suffers.

Technology should streamline research. Instead, it often complicates it. Fragmentation creates friction at every step of the upstream journey.

Retention begins long before the first study visit, but most strategies start too late.

The Sikara Framework for Clinical Trial Success

Most enrollment failures can be traced back to feasibility decisions made months before the first patient is approached. True readiness requires a multidimensional assessment and not a checkbox exercise.

Enrollment projections often reflect optimism rather than operational reality. A modern approach requires precision.

Risk Adjusted Forecasting: Incorporate variables such as staff turnover,competing trials, and seasonal patient flow.

Technology should simplify, streamline, and empower and not overwhelm.

Coordinators are the backbone of clinical research. Empowering mid-level managers and clinic staff will improve clinical outcomes.

Patient support services are not “nice to have” but essential infrastructure for equitable participation.

The Future of Enrollment Depends on Upstream Excellence

The enrollment crisis is not inevitable. It is the predictable result of fragmented systems, under‑resourced teams, and outdated assumptions about research’s value. The solution lies in readiness, infrastructure, technology, and leadership alignment.

At Sikara, we believe the future belongs to organizations that:

These are the systems that will lead in innovation, equity, and patient impact.

← Back to Insights